The Notch pathway: a novel therapeutic target for cardiovascular diseases?

References

• Miele L. Notch signaling. Clin Cancer Res. 2006;12(4):1074–1079.
   PubMed Web of Science ®Google Scholar
• D’Souza B, Meloty-Kapella L, Weinmaster G. Canonical and non-canonical Notch ligands. Curr Top Dev Biol. 2010;92:73–129.
   PubMed Web of Science ®Google Scholar
• Kovall RA, Gebelein B, Sprinzak D, et al. The Canonical Notch Signaling Pathway: structural and Biochemical Insights into Shape, Sugar, and Force. Dev Cell. 2017;41(3):228–241.
   PubMed Web of Science ®Google Scholar
• Brou C, Logeat F, Gupta N, et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell. 2000;5(2):207–216.
   PubMed Web of Science ®Google Scholar
• Struhl G, Greenwald I. Presenilin-mediated transmembrane cleavage is required for Notch signal transduction in Drosophila. Proc Natl Acad Sci U S A. 2001;98(1):229–234.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ, Wolfe MS. Presenilin: running with scissors in the membrane. Cell. 2007;131(2):215–221.
   PubMed Web of Science ®Google Scholar
• Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216–233.
   PubMed Web of Science ®Google Scholar
• Morel V, Lecourtois M, Massiani O, et al. Transcriptional repression by suppressor of hairless involves the binding of a hairless-dCtBP complex in Drosophila. Curr Biol. 2001;11(10):789–792.
   PubMed Web of Science ®Google Scholar
• Wallberg AE, Pedersen K, Lendahl U, et al. p300 and PCAF act cooperatively to mediate transcriptional activation from chromatin templates by notch intracellular domains in vitro. Mol Cell Biol. 2002;22(22):7812–7819.
   PubMed Web of Science ®Google Scholar
• Bray SJ. Notch signalling in context. Nat Rev Mol Cell Biol. 2016;17(11):722–735.
   PubMed Web of Science ®Google Scholar
• Skalska L, Stojnic R, Li J, et al. Chromatin signatures at Notch‐regulated enhancers reveal large‐scale changes in H3K56ac upon activation. Embo J. 2015;34(14):1889–1904.
   PubMed Web of Science ®Google Scholar
• Ayaz F, Osborne BA. Non-canonical notch signaling in cancer and immunity. Front Oncol. 2014;4:345.
   PubMedGoogle Scholar
• Siebel C, Lendahl U. Notch signaling in development, tissue homeostasis, and disease. Physiol Rev. 2017;97(4):1235–1294.
   PubMed Web of Science ®Google Scholar
• Palomero T, Ferrando A. Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia. Clin Lymphoma Myeloma. 2009;9(Suppl 3):S205–S210.
   PubMedGoogle Scholar
• Marcel N, Sarin A. Notch1 regulated autophagy controls survival and suppressor activity of activated murine T-regulatory cells. Elife. 2016 5.
   Google Scholar
• Yamamoto S, Schulze KL, Bellen HJ. Introduction to Notch signaling. Methods Mol Biol. 2014;1187:1–14.
   PubMedGoogle Scholar
• Borggrefe T, Lauth M, Zwijsen A, et al. The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGFbeta/BMP and hypoxia pathways. Biochim Biophys Acta. 2016;1863(2):303–313.
   PubMed Web of Science ®Google Scholar
• Andersson ER, Sandberg R, Lendahl U. Notch signaling: simplicity in design, versatility in function. Development. 2011;138(17):3593–3612.
   PubMed Web of Science ®Google Scholar
• Kakuda S, Haltiwanger RS. Deciphering the Fringe-Mediated Notch Code: identification of Activating and Inhibiting Sites Allowing Discrimination between Ligands. Dev Cell. 2017;40(2):193–201.
   PubMed Web of Science ®Google Scholar
• Aquila G, Fortini C, Pannuti A, et al. Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: a pilot study. J Transl Med. 2017;15(1):98.
   PubMed Web of Science ®Google Scholar
• Sprinzak D, Lakhanpal A, Lebon L, et al. Cis-interactions between Notch and Delta generate mutually exclusive signalling states. Nature. 2010;465(7294):86–90.
   PubMed Web of Science ®Google Scholar
• Osipo C, Golde TE, Osborne BA, et al. Off the beaten pathway: the complex cross talk between Notch and NF-kappaB. Lab Invest. 2008;88(1):11–17.
   PubMed Web of Science ®Google Scholar
• Fortini F, Vieceli Dalla Sega F, Caliceti C, et al. Estrogen-mediated protection against coronary heart disease: the role of the Notch pathway. J Steroid Biochem Mol Biol. 2019;189:87–100.
   PubMed Web of Science ®Google Scholar
• Aster JC, Pear WS, Blacklow SC. The varied roles of notch in cancer. Annu Rev Pathol. 2017;12:245–275.
   PubMed Web of Science ®Google Scholar
• Luxán G, D’Amato G, MacGrogan D, et al. Endocardial Notch signaling in cardiac development and disease. Circ Res. 2016;118(1):e1–e18.
   PubMed Web of Science ®Google Scholar
• Papoutsi T, Luna-Zurita L, Prados B, et al. Bmp2 and Notch cooperate to pattern the embryonic endocardium. Development. 2018.
   PubMed Web of Science ®Google Scholar
• de la Pompa JL, Epstein JA. Coordinating tissue interactions: notch signaling in cardiac development and disease. Dev Cell. 2012;22(2):244–254.
   PubMed Web of Science ®Google Scholar
• D’Amato G, Luxan G, de la Pompa JL. Notch signalling in ventricular chamber development and cardiomyopathy. Febs J. 2016;283(23):4223–4237.
   PubMed Web of Science ®Google Scholar
• Del Monte G, Grego-Bessa J, Gonzalez-Rajal A, et al. Monitoring Notch1 activity in development: evidence for a feedback regulatory loop. Dev Dyn. 2007;236(9):2594–2614.
   PubMed Web of Science ®Google Scholar
• Fischer A, Steidl C, Wagner TU, et al. Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circ Res. 2007;100(6):856–863.
   PubMed Web of Science ®Google Scholar
• Krebs LT, Shutter JR, Tanigaki K, et al. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 2004;18(20):2469–2473.
   PubMed Web of Science ®Google Scholar
• Duarte A, Hirashima M, Benedito R, et al. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 2004;18(20):2474–2478.
   PubMed Web of Science ®Google Scholar
• Krebs LT, Starling C, Chervonsky AV, et al. Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants. Genesis. 2010;48(3):146–150.
   PubMed Web of Science ®Google Scholar
• Mack JJ, Iruela-Arispe ML. NOTCH regulation of the endothelial cell phenotype. Curr Opin Hematol. 2018;25(3):212–218.
   PubMed Web of Science ®Google Scholar
• Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437(7056):270–274.
   PubMed Web of Science ®Google Scholar
• Preuss C, Capredon M, Wünnemann F, et al. Family based whole exome sequencing reveals the multifaceted role of Notch signaling in congenital heart disease. PLoS Genet. 2016;12(10):e1006335.
   PubMed Web of Science ®Google Scholar
• Ducharme V, Guauque-Olarte S, Gaudreault N, et al. NOTCH1 genetic variants in patients with tricuspid calcific aortic valve stenosis. J Heart Valve Dis. 2013;22(2):142–149.
   PubMed Web of Science ®Google Scholar
• Freylikhman O, Tatarinova T, Smolina N, et al. Variants in the NOTCH1 gene in patients with aortic coarctation. Congenit Heart Dis. 2014;9(5):391–396.
   PubMed Web of Science ®Google Scholar
• Irtyuga O, Malashicheva A, Zhiduleva E, et al. NOTCH1 Mutations in Aortic Stenosis: association with Osteoprotegerin/RANK/RANKL. Biomed Res Int. 2017;2017:6917907.
   PubMed Web of Science ®Google Scholar
• Guida V, Chiappe F, Ferese R, et al. Novel and recurrent JAG1 mutations in patients with tetralogy of Fallot. Clin Genet. 2011;80(6):591–594.
   PubMed Web of Science ®Google Scholar
• Page DJ, Miossec MJ, Williams SG, et al. Whole exome sequencing reveals the major genetic contributors to nonsyndromic tetralogy of fallot. Circ Res. 2019;124(4):553–563.
   PubMed Web of Science ®Google Scholar
• Iascone M, Ciccone R, Galletti L, et al. Identification of de novo mutations and rare variants in hypoplastic left heart syndrome. Clin Genet. 2012;81(6):542–554.
   PubMed Web of Science ®Google Scholar
• Southgate L, Sukalo M, Karountzos AS, et al. Haploinsufficiency of the NOTCH1 receptor as a cause of Adams–Oliver syndrome with variable cardiac anomalies. Circ Genomic Precis Med. 2015;8(4):572–581.
   Google Scholar
• Shaheen R, Aglan M, Keppler-Noreuil K, et al. Mutations in EOGT confirm the genetic heterogeneity of autosomal-recessive Adams-Oliver syndrome. Am J Hum Genet. 2013;92(4):598–604.
   PubMed Web of Science ®Google Scholar
• Kerstjens-Frederikse WS, van de Laar IM, Vos YJ, et al. Cardiovascular malformations caused by NOTCH1 mutations do not keep left: data on 428 probands with left-sided CHD and their families. Genet Med. 2016;18(9):914–923.
   PubMed Web of Science ®Google Scholar
• Spinner NB, Leonard LD, Krantz ID. Alagille syndrome. 2013. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1273/.
   Google Scholar
• Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383(6602):707.
   PubMed Web of Science ®Google Scholar
• Rutkovskiy A, Malashicheva A, Sullivan G, et al. Valve interstitial cells: the key to understanding the pathophysiology of heart valve calcification. J Am Heart Assoc. 2017;6(9).
   PubMed Web of Science ®Google Scholar
• Acharya A, Hans CP, Koenig SN, et al. Inhibitory role of Notch1 in calcific aortic valve disease. PloS One. 2011;6(11):e27743.
   PubMed Web of Science ®Google Scholar
• Nigam V, Srivastava D. Notch1 represses osteogenic pathways in aortic valve cells. J Mol Cell Cardiol. 2009;47(6):828–834.
   PubMed Web of Science ®Google Scholar
• Hadji F, Boulanger MC, Guay SP, et al. Altered DNA methylation of long noncoding RNA H19 in calcific aortic valve disease promotes mineralization by silencing NOTCH1. Circulation. 2016;134(23):1848–1862.
   PubMed Web of Science ®Google Scholar
• Zeng Q, Song R, Ao L, et al. Notch1 promotes the pro-osteogenic response of human aortic valve interstitial cells via modulation of ERK1/2 and nuclear factor-κB activation. Arterioscler Thromb Vasc Biol. 2013;33(7):1580–1590.
   PubMed Web of Science ®Google Scholar
• Theodoris CV, Li M, White MP, et al. Human disease modeling reveals integrated transcriptional and epigenetic mechanisms of NOTCH1 haploinsufficiency. Cell. 2015;160(6):1072–1086.
   PubMed Web of Science ®Google Scholar
• Kostina A, Shishkova A, Ignatieva E, et al. Different Notch signaling in cells from calcified bicuspid and tricuspid aortic valves. J Mol Cell Cardiol. 2018;114:211–219.
   PubMed Web of Science ®Google Scholar
• Michelena HI, Khanna AD, Mahoney D, et al. Incidence of aortic complications in patients with bicuspid aortic valves. Jama. 2011;306(10):1104–1112.
   PubMed Web of Science ®Google Scholar
• Davis FM, Rateri DL, Daugherty A. Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies. Heart. 2014;100(19):1498–1505.
   PubMed Web of Science ®Google Scholar
• Scheppke L, Murphy EA, Zarpellon A, et al. Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane. Blood. 2012;119(9):2149–2158.
   PubMed Web of Science ®Google Scholar
• Manderfield LJ, High FA, Engleka KA, et al. Notch activation of Jagged1 contributes to the assembly of the arterial wall. Circulation. 2012;125(2):314–323.
   PubMed Web of Science ®Google Scholar
• High FA, Lu MM, Pear WS, et al. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc Natl Acad Sci U S A. 2008;105(6):1955–1959.
   PubMed Web of Science ®Google Scholar
• Baeten JT, Lilly B. Notch signaling in vascular smooth muscle cells. Adv Pharmacol. 2017;78:351–382.
   PubMedGoogle Scholar
• Baeten JT, Lilly B. Differential regulation of NOTCH2 and NOTCH3 contribute to their unique functions in vascular smooth muscle cells. J Biol Chem. 2015;290(26):16226–16237.
   PubMed Web of Science ®Google Scholar
• Pedrosa A-R, Trindade A, Fernandes A-C, et al. Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1. Arterioscler Thromb Vasc Biol. 2015;35(5):1134–1146.
   PubMed Web of Science ®Google Scholar
• Kostina A, Semenova D, Kostina D, et al. Human aortic endothelial cells have osteogenic Notch-dependent properties in co-culture with aortic smooth muscle cells. Biochem Biophys Res Commun. 2019;514(2):462–468.
   PubMed Web of Science ®Google Scholar
• Koenig SN, LaHaye S, Feller JD, et al. Notch1 haploinsufficiency causes ascending aortic aneurysms in mice. JCI Insight. 2017;2(21):e91353.
   PubMed Web of Science ®Google Scholar
• Kostina AS, Uspensky VЕ, Irtyuga OB, et al. Notch-dependent EMT is attenuated in patients with aortic aneurysm and bicuspid aortic valve. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2016;1862(4):733–740.
   PubMed Web of Science ®Google Scholar
• Ignatieva E, Kostina D, Irtyuga O, et al. Mechanisms of smooth muscle cell differentiationare distinctly altered in thoracic aortic aneurysms associated with Bicuspid or Tricuspid Aortic Valves. Front Physiol. 2017;8.
   PubMed Web of Science ®Google Scholar
• Maleki S, Kjellqvist S, Paloschi V, et al. Mesenchymal state of intimal cells may explain higher propensity to ascending aortic aneurysm in bicuspid aortic valves. Sci Rep. 2016;6:35712.
   PubMed Web of Science ®Google Scholar
• Kostina A, Bjork H, Ignatieva E, et al. Notch, BMP and WNT/beta-catenin network is impaired in endothelial cells of the patients with thoracic aortic aneurysm. Atheroscler Suppl. 201835:e6–e13.
   PubMed Web of Science ®Google Scholar
• Malashicheva A, Kostina D, Kostina A, et al. (2016) Phenotypic and functional changes of endothelial and smooth muscle cells in thoracic aortic aneurysms. Int J Vasc Med. 2016;2016:3107879
   PubMed Web of Science ®Google Scholar
• Rostama B, Turner JE, Seavey GT, et al. DLL4/Notch1 and BMP9 interdependent signaling induces human endothelial cell quiescence via P27KIP1 and thrombospondin-1. Arterioscler Thromb Vasc Biol. 2015;35(12):2626–2637.
   PubMed Web of Science ®Google Scholar
• Morini MF, Dejana E. Transcriptional regulation of arterial differentiation via Wnt, Sox and Notch. Curr Opin Hematol. 2014;21(3):229–234.
   PubMed Web of Science ®Google Scholar
• Jahnsen ED, Trindade A, Zaun HC, et al. Notch1 is pan-endothelial at the onset of flow and regulated by flow. PloS One. 2015;10(4):e0122622.
   PubMed Web of Science ®Google Scholar
• Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling–concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000;35(3):569–582.
   PubMed Web of Science ®Google Scholar
• Ferrari R, Rizzo P. The Notch pathway: a novel target for myocardial remodelling therapy?. Eur Heart J. 2014;35(32):2140–2145.
   PubMed Web of Science ®Google Scholar
• Norum HM, Gullestad L, Abraityte A, et al. Increased serum levels of the Notch ligand DLL1 are associated with diastolic dysfunction, reduced exercise capacity, and adverse outcome in chronic heart failure. J Card Fail. 2016;22(3):218–223.
   Web of Science ®Google Scholar
• Norum HM, Broch K, Michelsen AE, et al. The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated Cardiomyopathy. J Cardiovasc Transl Res. 2017.
   PubMed Web of Science ®Google Scholar
• Chiplunkar A, Rentschler S. Notch Activation Associated with Poor Outcomes in Heart Failure: is it Harmful, or not Enough of a Good Thing?. J Card Fail. 2016;22(3):224–225.
   PubMed Web of Science ®Google Scholar
• Chiorean EG, LoRusso P, Strother RM, et al. A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors. Clin Cancer Res. 2015;21(12):2695–2703.
   PubMed Web of Science ®Google Scholar
• Smith DC, Eisenberg PD, Manikhas G, et al. A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors. Clin Cancer Res. 2014;20:6295–6303.
   Web of Science ®Google Scholar
• Rizzo P, Miele L, Ferrari R. The Notch pathway: a crossroad between the life and death of the endothelium. Eur Heart J. 2013;34(32):2504–2509.
   PubMed Web of Science ®Google Scholar
• Vieceli Dalla Sega F, Aquila G, Fortini F, et al. Context-dependent function of ROS in the vascular endothelium: the role of the Notch pathway and shear stress. Biofactors. 2017;43(4):475–485.
   PubMed Web of Science ®Google Scholar
• Briot A, Civelek M, Seki A, et al. Endothelial NOTCH1 is suppressed by circulating lipids and antagonizes inflammation during atherosclerosis. J Exp Med. 2015;212(12):2147–2163.
   PubMed Web of Science ®Google Scholar
• Aquila G, Morelli MB, Vieceli Dalla Sega F, et al. Heart rate reduction with ivabradine in the early phase of atherosclerosis is protective in the endothelium of ApoE-deficient mice. J Physiol Pharmacol. 2018;69(1):35–52.
   PubMed Web of Science ®Google Scholar
• Mack JJ, Mosqueiro TS, Archer BJ, et al. NOTCH1 is a mechanosensor in adult arteries. Nat Commun. 2017;8(1):1620.
   PubMed Web of Science ®Google Scholar
• Polacheck WJ, Kutys ML, Yang J, et al. A non-canonical Notch complex regulates adherens junctions and vascular barrier function. Nature. 2017;552(7684):258–262.
   PubMed Web of Science ®Google Scholar
• Jabs M, Rose AJ, Lehmann LH, et al. Inhibition of Endothelial Notch Signaling Impairs Fatty Acid Transport and Leads to Metabolic and Vascular Remodeling of the Adult Heart. Circulation. 2018;137:2592–2608.
   PubMed Web of Science ®Google Scholar
• Verginelli F, Adesso L, Limon I, et al. Activation of an endothelial Notch1-Jagged1 circuit induces VCAM1 expression, an effect amplified by interleukin-1beta. Oncotarget. 2015;6(41):43216–43229.
   PubMedGoogle Scholar
• Nus M, Martinez-Poveda B, MacGrogan D, et al. Endothelial Jag1-RBPJ signalling promotes inflammatory leucocyte recruitment and atherosclerosis. Cardiovasc Res. 2016;112:568–580.
   PubMed Web of Science ®Google Scholar
• Poulsen LC, Edelmann RJ, Kruger S, et al. Inhibition of Endothelial NOTCH1 Signaling Attenuates Inflammation by Reducing Cytokine-Mediated Histone Acetylation at Inflammatory Enhancers. Arterioscler Thromb Vasc Biol. 2018;38(4):854–869.
   PubMed Web of Science ®Google Scholar
• Guruharsha KG, Kankel MW, Artavanis-Tsakonas S. The Notch signalling system: recent insights into the complexity of a conserved pathway. Nat Rev Genet. 2012;13(9):654–666.
   PubMed Web of Science ®Google Scholar
• Shang Y, Smith S, Hu X. Role of Notch signaling in regulating innate immunity and inflammation in health and disease. Protein Cell. 2016;7(3):159–174.
   PubMed Web of Science ®Google Scholar
• Vieceli Dalla Sega F, Fortini F, Aquila G, et al. Notch signaling regulates immune response in atherosclerosis. Front Immunol. 2019.
   PubMed Web of Science ®Google Scholar
• Rizzo P, Ferrari R. The Notch pathway: a new therapeutic target in atherosclerosis?. Eur Heart J Suppl. 2015;17(suppl_A):A74–A76.
   Web of Science ®Google Scholar
• Kerr BA, West XZ, Kim YW, et al. Stability and function of adult vasculature is sustained by Akt/Jagged1 signalling axis in endothelium. Nat Commun. 2016;7:10960.
   PubMed Web of Science ®Google Scholar
• Clement N, Gueguen M, Glorian M, et al. Notch3 and IL-1beta exert opposing effects on a vascular smooth muscle cell inflammatory pathway in which NF-kappaB drives crosstalk. J Cell Sci. 2007;120(Pt 19):3352–3361.
   PubMed Web of Science ®Google Scholar
• Boucher JM, Peterson SM, Urs S, et al. The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells. J Biol Chem. 2011;286(32):28312–28321.
   PubMed Web of Science ®Google Scholar
• Chen Q, Yang F, Guo M, et al. miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration. J Mol Cell Cardiol. 2015;89(Pt A):75–86.
   PubMed Web of Science ®Google Scholar
• Redmond EM, Liu W, Hamm K, et al. Perivascular delivery of Notch 1 siRNA inhibits injury-induced arterial remodeling. PLoS One. 2014;9(1):e84122.
   PubMed Web of Science ®Google Scholar
• Wu JR, Yeh JL, Liou SF, et al. Gamma-secretase Inhibitor Prevents Proliferation and Migration of Ductus Arteriosus Smooth Muscle Cells through the Notch3-HES1/2/5 Pathway. Int J Biol Sci. 2016;12(9):1063–1073.
   PubMed Web of Science ®Google Scholar
• Jiang D, Zhuang J, Peng W, et al. Phospholipase Cgamma1 Mediates Intima Formation Through Akt-Notch1 Signaling Independent of the Phospholipase Activity. J Am Heart Assoc. 2017;6(7).
   Web of Science ®Google Scholar
• Aquila G, Marracino L, Martino V, et al. The Use of Nutraceuticals to Counteract Atherosclerosis: the Role of the Notch Pathway. Oxid Med Cell Longev. 2019;(2019):30.
   Web of Science ®Google Scholar
• Ruan ZB, Fu XL, Li W, et al. Effect of notch1,2,3 genes silicing on NF-kappaB signaling pathway of macrophages in patients with atherosclerosis. Biomed Pharmacother. 2016;84:666–673.
   PubMed Web of Science ®Google Scholar
• Singla DK, Wang J, Singla R. Primary human monocytes differentiate into M2 macrophages and involve Notch-1 pathway. Can J Physiol Pharmacol. 2017;95(3):288–294.
   PubMed Web of Science ®Google Scholar
• Huang F, Zhao JL, Wang L, et al. miR-148a-3p Mediates Notch Signaling to Promote the Differentiation and M1 Activation of Macrophages. Front Immunol. 2017;8:1327.
   PubMed Web of Science ®Google Scholar
• Xu J, Chi F, Guo T, et al. NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation. J Clin Invest. 2015;125(4):1579–1590.
   PubMed Web of Science ®Google Scholar
• Fung E, Tang SM, Canner JP, et al. Delta-like 4 induces notch signaling in macrophages: implications for inflammation. Circulation. 2007;115(23):2948–2956.
   PubMed Web of Science ®Google Scholar
• Pagie S, Gerard N, Charreau B. Notch signaling triggered via the ligand DLL4 impedes M2 macrophage differentiation and promotes their apoptosis. Cell Commun Signal. 2018;16(1):4.
   PubMed Web of Science ®Google Scholar
• Pabois A, Pagie S, Gerard N, et al. Notch signaling mediates crosstalk between endothelial cells and macrophages via Dll4 and IL6 in cardiac microvascular inflammation. Biochem Pharmacol. 2016;104:95–107.
   PubMed Web of Science ®Google Scholar
• Nakano T, Fukuda D, Koga J, et al. Delta-Like Ligand 4-Notch Signaling in Macrophage Activation. Arterioscler Thromb Vasc Biol. 2016;36(10):2038–2047.
   PubMed Web of Science ®Google Scholar
• Foldi J, Chung AY, Xu H, et al. Autoamplification of Notch signaling in macrophages by TLR-induced and RBP-J-dependent induction of Jagged1. J Immunol. 2010;185(9):5023–5031.
   PubMed Web of Science ®Google Scholar
• Kimball AS, Joshi AD, Boniakowski AE, et al. Notch Regulates Macrophage-Mediated Inflammation in Diabetic Wound Healing. Front Immunol. 2017;8:635.
   PubMed Web of Science ®Google Scholar
• Gamrekelashvili J, Giagnorio R, Jussofie J, et al. Regulation of monocyte cell fate by blood vessels mediated by Notch signalling. Nat Commun. 2016;7:12597.
   PubMed Web of Science ®Google Scholar
• Libby P, Hansson GK. Taming Immune and Inflammatory Responses to Treat Atherosclerosis. J Am Coll Cardiol. 2018;71(2):173–176.
   PubMed Web of Science ®Google Scholar
• Libby P, Ebert BL. CHIP (Clonal Hematopoiesis of Indeterminate Potential). Circulation. 2018;138(7):666–668.
   PubMed Web of Science ®Google Scholar
• Radtke F, MacDonald HR, Tacchini-Cottier F. Regulation of innate and adaptive immunity by Notch. Nat Rev Immunol. 2013;13(6):427–437.
   PubMed Web of Science ®Google Scholar
• Hossain F, Majumder S, Ucar DA, et al. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses. Front Immunol. 2018;9:1288.
   PubMed Web of Science ®Google Scholar
• Collesi C, Felician G, Secco I, et al. Reversible Notch1 acetylation tunes proliferative signalling in cardiomyocytes. Cardiovasc Res. 2018;114(1):103–122.
   PubMed Web of Science ®Google Scholar
• Felician G, Collesi C, Lusic M, et al. Epigenetic modification at Notch responsive promoters blunts efficacy of inducing notch pathway reactivation after myocardial infarction. Circ Res. 2014;115(7):636–649.
   PubMed Web of Science ®Google Scholar
• Metrich M, Bezdek PA, Berthonneche C, et al. Jagged1 intracellular domain-mediated inhibition of Notch1 signalling regulates cardiac homeostasis in the postnatal heart. Cardiovasc Res. 2015;108(1):74–86.
   PubMed Web of Science ®Google Scholar
• Pei H, Yu Q, Xue Q, et al. Notch1 cardioprotection in myocardial ischemia/reperfusion involves reduction of oxidative/nitrative stress. Basic Res Cardiol. 2013;108(5):373.
   PubMed Web of Science ®Google Scholar
• Pei H, Song X, Peng C, et al. TNF-alpha inhibitor protects against myocardial ischemia/reperfusion injury via Notch1-mediated suppression of oxidative/nitrative stress. Free Radic Biol Med. 2015;82:114–121.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang C, Hu J, et al. Notch3/Akt signaling contributes to OSM-induced protection against cardiac ischemia/reperfusion injury. Apoptosis. 2015;20(9):1150–1163.
   PubMed Web of Science ®Google Scholar
• Wu F, Yu B, Zhang X, et al. Cardioprotective effect of Notch signaling on the development of myocardial infarction complicated by diabetes mellitus. Exp Ther Med. 2017;14(4):3447–3454.
   PubMed Web of Science ®Google Scholar
• Meng X, Ji Y, Wan Z, et al. Inhibition of miR-363 protects cardiomyocytes against hypoxia-induced apoptosis through regulation of Notch signaling. Biomed Pharmacother. 2017;90:509–516.
   PubMed Web of Science ®Google Scholar
• Rocca C, Femmino S, Aquila G, et al. Notch1 Mediates Preconditioning Protection Induced by GPER in Normotensive and Hypertensive Female Rat Hearts. Front Physiol. 2018;9:521.
   PubMed Web of Science ®Google Scholar
• Zhang M, Yu LM, Zhao H, et al. 2,3,5,4ʹ-Tetrahydroxystilbene-2-O-beta-D-glucoside protects murine hearts against ischemia/reperfusion injury by activating Notch1/Hes1 signaling and attenuating endoplasmic reticulum stress. Acta Pharmacol Sin. 2017;38(3):317–330.
   PubMed Web of Science ®Google Scholar
• Yu L, Li F, Zhao G, et al. Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling. Apoptosis. 2015;20(6):796–810.
   PubMed Web of Science ®Google Scholar
• Yu B, Song B. Notch 1 signalling inhibits cardiomyocyte apoptosis in ischaemic postconditioning. Heart Lung Circ. 2014;23(2):152–158.
   PubMed Web of Science ®Google Scholar
• Zhou XL, Wan L, Xu QR, et al. Notch signaling activation contributes to cardioprotection provided by ischemic preconditioning and postconditioning. J Transl Med. 2013;11:251.
   PubMed Web of Science ®Google Scholar
• Boni A, Urbanek K, Nascimbene A, et al. Notch1 regulates the fate of cardiac progenitor cells. Proc Natl Acad Sci U S A. 2008;105(40):15529–15534.
   PubMed Web of Science ®Google Scholar
• Nemir M, Metrich M, Plaisance I, et al. The Notch pathway controls fibrotic and regenerative repair in the adult heart. Eur Heart J. 2014;35(32):2174–2185.
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. Targeting the transforming growth factor (TGF)-beta cascade in the remodeling heart: benefits and perils. J Mol Cell Cardiol. 2014;76:169–171.
   PubMed Web of Science ®Google Scholar
• Sassoli C, Chellini F, Pini A, et al. Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-beta/Smad3 signaling. PLoS One. 2013;8(5):e63896.
   PubMed Web of Science ®Google Scholar
• Zhou XL, Fang YH, Wan L, et al. Notch signaling inhibits cardiac fibroblast to myofibroblast transformation by antagonizing TGF-beta1/Smad3 signaling. J Cell Physiol. 2018;234(6):8834–8845.
   Web of Science ®Google Scholar
• Boopathy AV, Martinez MD, Smith AW, et al. Intramyocardial Delivery of Notch Ligand-Containing Hydrogels Improves Cardiac Function and Angiogenesis Following Infarction. Tissue Eng Part A. 2015;21(17–18):2315–2322.
   PubMed Web of Science ®Google Scholar
• King KR, Aguirre AD, Ye YX, et al. IRF3 and type I interferons fuel a fatal response to myocardial infarction. Nat Med. 2017;23(12):1481–1487.
   PubMed Web of Science ®Google Scholar
• Svensson A, Jakara E, Shestakov A, et al. Inhibition of gamma-secretase cleavage in the notch signaling pathway blocks HSV-2-induced type I and type II interferon production. Viral Immunol. 2010;23(6):647–651.
   PubMed Web of Science ®Google Scholar
• Arumugam TV, Chan SL, Jo DG, et al. Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke. Nat Med. 2006;12(6):621–623.
   PubMed Web of Science ®Google Scholar
• Yin J, Hu H, Li X, et al. Inhibition of Notch signaling pathway attenuates sympathetic hyperinnervation together with the augmentation of M2 macrophages in rats post-myocardial infarction. Am J Physiol Cell Physiol. 2016;310(1):C41–C53.
   PubMed Web of Science ®Google Scholar
• van der Laan AM, Piek JJ, Van Royen N. Targeting angiogenesis to restore the microcirculation after reperfused MI. Nat Rev Cardiol. 2009;6(8):515–523.
   PubMed Web of Science ®Google Scholar
• Gridley T. Notch signaling in vascular development and physiology. Development. 2007;134(15):2709–2718.
   PubMed Web of Science ®Google Scholar
• Kratsios P, Catela C, Salimova E, et al. Distinct roles for cell-autonomous Notch signaling in cardiomyocytes of the embryonic and adult heart. Circ Res. 2010;106(3):559–572.
   PubMed Web of Science ®Google Scholar
• Diaz-Trelles R, Scimia MC, Bushway P, et al. Notch-independent RBPJ controls angiogenesis in the adult heart. Nat Commun. 2016;7:12088.
   PubMed Web of Science ®Google Scholar
• Pannella M, Caliceti C, Fortini F, et al. Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells. J Cell Physiol. 2016;231(12):2700–2710.
   PubMed Web of Science ®Google Scholar
• Restivo G, Nguyen BC, Dziunycz P, et al. IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes. Embo J. 2011;30(22):4571–4585.
   PubMed Web of Science ®Google Scholar
• South AP, Cho RJ, Aster JC. The double-edged sword of Notch signaling in cancer. Semin Cell Dev Biol. 2012;23(4):458–464.
   PubMed Web of Science ®Google Scholar
• Visvader JE. Cells of origin in cancer. Nature. 2011;469(7330):314–322.
   PubMed Web of Science ®Google Scholar
• Plaks V, Kong N, Werb Z. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?. Cell Stem Cell. 2015;16(3):225–238.
   PubMed Web of Science ®Google Scholar
• Pannuti A, Foreman K, Rizzo P, et al. Targeting Notch to target cancer stem cells. Clin Cancer Res. 2010;16(12):3141–3152.
   PubMed Web of Science ®Google Scholar
• Takebe N, Miele L, Harris PJ, et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol. 2015;12(8):445–464.
   PubMed Web of Science ®Google Scholar
• Banerjee MN, Bolli R, Hare JM. Clinical Studies of Cell Therapy in Cardiovascular Medicine: recent Developments and Future Directions. Circ Res. 2018;123(2):266–287.
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu L, Li Y, et al. Hypoxic Preconditioning Enhances Biological Function of Endothelial Progenitor Cells via Notch-Jagged1 Signaling Pathway. Med Sci Monit. 2017;23:4665–4667.
   PubMed Web of Science ®Google Scholar
• Bollini S, Smits AM, Balbi C, et al. Triggering Endogenous Cardiac Repair and Regeneration via Extracellular Vesicle-Mediated Communication. Front Physiol. 2018;9:1497.
   PubMed Web of Science ®Google Scholar
• Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324(5923):98–102.
   PubMed Web of Science ®Google Scholar
• Cesselli D, Beltrami AP, D’Aurizio F, et al. Effects of age and heart failure on human cardiac stem cell function. Am J Pathol. 2011;179(1):349–366.
   PubMed Web of Science ®Google Scholar
• Secco I, Barile L, Torrini C, et al. Notch pathway activation enhances cardiosphere in vitro expansion. J Cell Mol Med. 2018;22(11):5583–5595.
   PubMed Web of Science ®Google Scholar
• Plaisance I, Perruchoud S, Fernandez-Tenorio M, et al. Cardiomyocyte Lineage Specification in Adult Human Cardiac Precursor Cells Via Modulation of Enhancer-Associated Long Noncoding RNA Expression. JACC Basic Transl Sci. 2016;1(6):472–493.
   PubMedGoogle Scholar
• Kretzschmar K, Post Y, Bannier-Helaouet M, et al. Profiling proliferative cells and their progeny in damaged murine hearts. Proc Natl Acad Sci U S A. 2018;115(52):E12245–E12254.
   PubMed Web of Science ®Google Scholar
• Jaiswal S, Natarajan P, Silver AJ, et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. N Engl J Med. 2017;377(2):111–121.
   PubMed Web of Science ®Google Scholar
• Meijers WC, Maglione M, Bakker SJL, et al. The Failing Heart Stimulates Tumor Growth by Circulating Factors. Circulation. 2018.
   Web of Science ®Google Scholar
• Bertero E, Canepa M, Maack C, et al. Linking Heart Failure to Cancer. Circulation. 2018;138(7):735–742.
   PubMed Web of Science ®Google Scholar
• Hicks BM, Filion KB, Yin H, et al. Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study. BMJ. 2018;363:k4209.
   Google Scholar
• Van Wyhe RD, Rahal OM, Woodward WA. Effect of statins on breast cancer recurrence and mortality: a review. Breast Cancer (Dove Med Press). 2017;9:559–565.
   PubMed Web of Science ®Google Scholar
• Zeboudj L, Maitre M, Guyonnet L, et al. Selective EGF-Receptor Inhibition in CD4(+) T Cells Induces Anergy and Limits Atherosclerosis. J Am Coll Cardiol. 2018;71(2):160–172.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017;377(12):1119–1131.
   PubMed Web of Science ®Google Scholar
• Kraft L, Erdenesukh T, Sauter M, et al. Blocking the IL-1β signalling pathway prevents chronic viral myocarditis and cardiac remodeling. Basic Res Cardiol. 2019;114(2):11.
   Google Scholar
• Tamagnone L, Zacchigna S, Rehman M. Taming the Notch Transcriptional Regulator for Cancer Therapy. Molecules. 2018;23(2):431.
   PubMed Web of Science ®Google Scholar
• Jimeno A, Moore KN, Gordon M, et al. A first-in-human phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody navicixizumab (OMP-305B83) in patients with previously treated solid tumors. Invest New Drugs. 2018;37(3):461–472.
   PubMed Web of Science ®Google Scholar
• Pant S, Jones SF, Kurkjian CD, et al. A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer. Eur J Cancer. 2016;56:1–9.
   PubMed Web of Science ®Google Scholar
• Knoechel B, Bhatt A, Pan L, et al. Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the gamma-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case. Cold Spring Harb Mol Case Stud. 2015;1(1):a000539.
   PubMed Web of Science ®Google Scholar
• Dotto GP. Notch tumor suppressor function. Oncogene. 2008;27(38):5115–5123.
   PubMed Web of Science ®Google Scholar
• Osborne B, Miele L. Notch and the immune system. Immunity. 1999;11(6):653–663.
   PubMed Web of Science ®Google Scholar
• Rizzo P, Mele D, Caliceti C, et al. The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors. Front Oncol. 2014;4:384.
   PubMed Web of Science ®Google Scholar
• Fortini F, Vieceli Dalla Sega F, Caliceti C, et al. Estrogen receptor beta-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor alpha (TNFalpha)-induced apoptosis. J Biol Chem. 2017;292(44):18178–18191.
   PubMed Web of Science ®Google Scholar
• Katsuki S, Matoba T, Koga JI, et al. Anti-inflammatory Nanomedicine for Cardiovascular Disease. Front Cardiovasc Med. 2017;4:87.
   PubMed Web of Science ®Google Scholar
• Huang Y, Qi Y, Du JQ, et al. MicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4. Expert Opin Ther Targets. 2014;18(12):1355–1365.
   PubMed Web of Science ®Google Scholar
• Iannolo G, Sciuto MR, Raffa GM, et al. MiR34 inhibition induces human heart progenitor proliferation. Cell Death Dis. 2018;9(3):368.
   PubMed Web of Science ®Google Scholar
• Schober A, Nazari-Jahantigh M, Wei Y, et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med. 2014;20(4):368–376.
   PubMed Web of Science ®Google Scholar
• Sundararaman S, Miller TJ, Pastore JM, et al. Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure. Gene Ther. 2011;18(9):867–873.
   PubMed Web of Science ®Google Scholar